News

Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra(R), Zestra Glide(R), EjectDelay(R), Sensum+(R) and Vesele(R) in Turkey and Select African and Gulf Countries
Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros(R) (Alprostadil) in Canada (Nasdaq_APRI)
Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa(TM) in the Middle East and the Gulf (Nasdaq_APRI)
Elis Pharma Introduces Erectile Dysfunction Drug, Vitaros(R) Licensed From Apricus Biosciences at Major Pharmaceutical Conference in Dubai
Elis Pharma Introduces Erectile Dysfunction Drug, Vitaros(R) Licensed From Apricus Biosciences at Major Pharmaceutical Conference in Dubai – WSJ
Elis Pharma Introduces Erectile Dysfunction Drug Vitaros(R) Licensed From Apricus Biosciences at Major Pharmaceutical Conference in Dubai
Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East
Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East 2
Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East (Nasdaq_APRI)
NEXMED Developing Patient Friendly Drugs
WSJ-Elis Pharma Introduces Erectile Dysfunction Drug, Vitaros(R) Licensed From Apricus Biosciences at Major Pharmaceutical Conference in Dubai – WSJ
NASDAQ Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East (Nasdaq_APRI) 2
NASDAQ Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East (Nasdaq_APRI)
PABME 2009 – 193716
PABME 2009 – 193717
AMEinfo Vitaros 253366
AMEinfo Vitaros 253365